Navigation Links
David Sveen Added to Heska's Board of Directors
Date:12/2/2013

LOVELAND, Colo., Dec. 2, 2013 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today that David Sveen, Ph.D. had joined Heska's Board of Directors.

Dr. Sveen is the President of Cedarstone Partners, Inc., an accounting and consulting practice for nonprofit organizations, which he founded in 1993.   Dr. Sveen has also been an adjunct assistant professorship of Christian Formation and Ministry at Wheaton College since 1995.  His professional background includes 13 years in senior management with the investment banking firm Griffin, Kubik, Stephens and Thompson. 

Dr. Sveen earned his BS in Business from Northern Illinois University in 1978 and his MBA from DePaul University in 1986.  In 1994 he earned his MA in Educational Ministries from Wheaton Graduate School and in 2004 his Ph.D. in Theological Education from Trinity Evangelical Divinity School.

"Several years ago, I enjoyed success with Kevin Wilson, while serving together on the Board at Sound Technologies, a digital imaging firm Kevin founded and successfully sold," said Dr. Sveen.  "Today, I am excited to be reunited in another opportunity with Kevin and others from that winning team as they join the many talented people at Heska.  I look forward to working with them as we form a culture of execution in this new and exciting chapter at Heska."

"We are pleased to add someone with Dr. Sveen's experience and judgment to our Board," commented Robert Grieve, Heska's Chairman and Chief Executive Officer. "We are convinced Dr. Sveen will help us on our mission of improving our business and creating shareholder value."

About Heska
Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and other specialty veterinary products.  Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines.  The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians.  For further information on Heska and its products, visit the company's website at www.heska.com.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties. There are uncertainties regarding the ability of any Board member, or the Board of Directors as a group, to impact Heska's operating and financial performance; uncertainties related to relying on past performance to predict future success; risks relating to any individual's judgment as to how another individual, or group of individuals, will perform in the future; uncertainties related to Heska's ability to retain its current Board members; risks related to Heska's ability to sell and market its products in an economically sustainable manner; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Quarterly Report on Form 10-Q for the quarter ended September 30, 2013.


'/>"/>
SOURCE Heska Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InspireMD Appoints David Blossom as Vice President of Global Marketing and Strategy
2. Dr. David Hangauer, Chief Scientific Officer and Co-Founder, commits his career to Kinex Pharmaceuticals
3. David H. Chung Joins AcelRx Pharmaceuticals as Chief Commercial Officer
4. Law Offices of John David Hart: What Went Wrong with the Stryker ShapeMatch Cutting Guides?
5. PDL BioPharma Appoints David Montez as Controller and Chief Accounting Officer
6. Protagonist Therapeutics Names David Liu Chief Scientific Officer
7. Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg
8. Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer
9. Dr. David Altamira Announces New Non-Surgical Procedures
10. Dr. David Altamira Offering Enhanced Breast Implant Houston Consultations
11. MetaStat Appoints David Epstein, Ph.D. as Advisor to Lead Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
Breaking Medicine Technology:
(Date:4/22/2017)... , ... April 22, 2017 ... ... of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its “Woman-Owned ... PROSHRED® Philadelphia specializes in providing information destruction , recycling, and ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article ... of ancient teeth, which reveal a great deal about prehistoric ice-age dental practitioners and ... may have been used to remove decayed dental matter, and that teeth were then ...
(Date:4/21/2017)... ... April 21, 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, ... is a benign bony lump located on the forehead usually attributed to a facial ... sight and pain. Dr. Shah has discovered an approach that is minimally invasive. He ...
(Date:4/21/2017)... ... 2017 , ... Dudnyk has announced the launch of its new brand identity, ... potential of specialty and orphan brands can only be achieved when the needs and ... Effect is at the heart of a true partnership between our agency and our ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
Breaking Medicine News(10 mins):